Durham, NCNCT05773001Now EnrollingIRB Ready

Respiratory Viral Infection Clinical Trial in Durham, NC

Access cutting-edge respiratory viral infection treatment through this phase 1 clinical trial at a research site in Durham. Study-provided care at no cost to qualified participants.

Sponsored by Robert Tighe, MD

Quick Self-Assessment

See if you qualify for this Durham location

Preparing your pre-screening questions…

Expert Care in Durham

Access respiratory viral infection specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related respiratory viral infection treatment provided free

Apply for This Durham Location

Check if you qualify for this respiratory viral infection clinical trial in Durham, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Durham

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Durham site if eligible
  4. 4Begin participation

About This Respiratory Viral Infection Study in Durham

The purpose of this research study to understand how prior respiratory infections affect the susceptibility to lung inflammation following environmental exposures.

Sponsor: Robert Tighe, MD

Who Can Participate

Inclusion Criteria

Individuals between 18-55 yrs. of age (No subject will be excluded from the study on the basis of gender or ethnicity)
Individuals with knowledge of prior respiratory viral infection history allowing them to be segregated into one of three cohorts
Cohort 1 - No history of respiratory viral infection (defined as no symptoms consistent with respiratory viral infection nor history of a positive respiratory viral test)
Cohort 2 - Documented mild respiratory viral infection (a positive test, either PCR- or antigen-based) but with mild to no symptoms and no evidence of a lower respiratory tract infection (including no hospitalization, and no oxygen use)
Cohort 3 - History of respiratory viral infection and symptoms/imaging consistent with a lower respiratory tract infection who have recovered, are \>6 months out from their infection, and have normal lung function (spirometry with FVC, FEV1 and FEV1/FVC)
There will be no maximal period from respiratory viral infection for inclusion in the study, the minimal period will be \>6 months out from infection

Exclusion Criteria

Individuals with prior respiratory viral pneumonia who have ongoing respiratory symptoms, are still using supplemental oxygen, or have abnormal lung function
Current smokers of tobacco products including e-cigarettes or those with previous smoking history within the prior 5 years
Pregnant women and women who are presently lactating.
Subjects that have received antibiotic administration or an upper respiratory infection within the previous 4 weeks
College and graduate students or employees who are under direct supervision by any of the investigators in this protocol
Alcohol or illicit substance abuse
Chronic cardio/pulmonary respiratory disorders or other medical conditions as determined by the investigator
Increased airway hyperresponsiveness at baseline as measured by a positive methacholine challenge response (methacholine PC20 FEV1 \< 4 mg/ml)
Subjects will be requested to refrain from antihistamines, nonsteroidal anti-inflammatory agents, antioxidants (e.g. beta-carotene, selenium, and lutein) and supplemental vitamins (e.g. C and E), for 1 week prior to, and during testing.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Durham?

Yes, this clinical trial (NCT05773001) has an active research site in Durham, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Respiratory Viral Infection Treatment Options in Durham, NC

If you're searching for respiratory viral infection treatment options in Durham, NC, this clinical trial (NCT05773001) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Durham research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced respiratory viral infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all respiratory viral infection clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Durham, NC

See all rheumatoid arthritis clinical trials recruiting in Durham — not just this study.

Browse Rheumatoid Arthritis Trials in Durham →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsAll Conditions →

Ready to Join in Durham?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Durham, NC